梓榆
Lv1
25 积分
2021-03-06 加入
-
CHOP versus CNOP (N = mitoxantrone) in non-Hodgkin's lymphoma: an interim report comparing efficacy and toxicity
22小时前
求助中
-
[Mitoxantrone-containing combination chemotherapy in patients with non-Hodgkin's lymphoma]
22小时前
求助中
-
First-line sintilimab with pegaspargase, gemcitabine, and oxaliplatin in advanced extranodal natural killer/T cell lymphoma (SPIRIT): a multicentre, single-arm, phase 2 trial
28天前
已完结
-
International uniform response criteria for multiple myeloma
1个月前
已完结
-
Outcomes of Relapsed or Refractory Diffuse Large B-Cell Lymphoma Treated With R-GemOx: A Multicenter Cohort Stud
1个月前
已完结
-
Outcomes of Relapsed or Refractory Diffuse Large B-Cell Lymphoma Treated With R-GemOx: A Multicenter Cohort Study
1个月前
已完结
-
MINE (mesna, ifosfamide, mitoxantrone, etoposide) Chemotherapy as a Treatment of Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma
1个月前
已完结
-
A phase II trial of oral etoposide with mitoxantrone and ifosfamide/mesna consolidated with intravenous etoposide, methylprednisolone, high-dose arabinoside, and cisplatin as salvage therapy for relapsing and/or refractory lymphomas
1个月前
已完结
-
Extramedullary multiple myeloma
1个月前
已完结
-
Management of Newly Diagnosed Multiple Myeloma Today, and in the Future
1个月前
已完结